Skip to main content

Table 2 Relapse and health outcome week 1 and 3 months

From: Feasibility and patient satisfaction with smoking cessation interventions for prevention of healthcare-associated infections in inpatients

 

Intervention (n = 17)

Usual care (n = 22)

Total (n = 39)

P-value*

Outcomes at week 1

    

 Smoking since DC(%)

11/16 (68.7 %)

14/21 (66.6 %)

25/37 (67.6 %)

1.000

 Alcohol (%)

1/16 (6.3 %)

2/21 (9.5 %)

3/37

1.000

 Quit Line (%)a

0/8

0/12

0/20

-

 Other cessation program/Medication Use (%)a

2/8 (25.0 %)

0/12

2/20 (1.0 %)

0.164

 Infection during stay (%)

0/16

1/21 (4.8 %)

1/37 (2.7 %)

1.000

 Infection Post DC (%)

1/16 (6.3 %)

2/21 (9.5 %)

3/37 (8.1 %)

1.00

 ER visit (%)b

2/17 (11.8 %)

2/22 (9.1 %)

4/39 (10.3 %)

0.568

 Hospital readmission (%)b

1/17 (5.9 %)

2/22 (9.1 %)

3/39 (7.7 %)

0.496

Outcomes at 3 months

    

 Smoking in last 7 days (%)

8/12 (66.7 %)

11/15 (73.3 %)

19/27 (70.4 %)

1.000

 Smoking at all since DC (%)

10/12 (83.3 %)

14/15 (93.3 %)

24/27 (88.9 %)

0.569

 Alcohol (%)

3/12 (25.0 %)

4/15 (26.7 %)

7/27 (25.9 %)

1.00

 Quit Line (%)

0/11

0/14

0/25

-

 Other cessation program/Medication Use (%)

2/11 (18.2 %)

1/14 (7.1 %)

3/25 (12 %)

1.000

 Infection Post DC (%)

1/11 (9.1 %)

4/15 (26.7 %)

5/26 (19.2 %)

0.614

 ER visit (%)b

7/17 (41.2 %)

7/22 (31.8 %)

14/39 (35.9 %)

0.689

 Hospital readmission (%)b

4/17 (23.5 %)

8/22 (36.4 %)

12/39 (30.8 %)

1.000

  1. *Data analyzed using Fisher’s exact analysis
  2. aQuit Line and other program/medication use was included in the week 1 outcome follow-up beginning with patient 18 and in the 3 month outcome follow-up with subject 4
  3. bER visitation and Hospital readmission data were compiled from self-report and medical records data